This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
N06DA
1 out of 7 registries used, show all original rules.
11184
Check minimum number of events
Min. number of events
3
11184
Include endpoints None
11184
Remove individuals based on genotype QC
10807
ADMED_ACHEI
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Use of anticholinesterases
based on the number of shared cases.
Broader endpoints:
- N06DA Anticholinesterases
- Alzheimer’s disease, wide definition (more control exclusions)
- Alzheimer’s disease, wide definition
- Dementia
- Dementia, including avohilmo
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 10807 | 4902 | 5905 |
| Unadjusted prevalence (%) | 2.62 | 2.13 | 3.25 |
| Mean age at first event (years) | 77.87 | 77.98 | 77.77 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ADMED_ACHEI – Use of anticholinesterases
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Use of anticholinesterases
↥Endpoint not on priority list, no data to show.